Discussion about this post

User's avatar
Gary Hawkins's avatar

Similarly, as anyone who has read through VAERS reports knows as well as we do ... there are an overwhelming number of repeated sentences. One might theorize this is intentional to switch the reader's brain off as an agency would surely want quality to be their reputation, the presenting of sloppiness would not be an option.

I would be interested in a regular expression or method to replace repeated strings of 50 or more characters with something like [echo87]

Expand full comment
Devon Brewer's avatar

Thank you, Aravind, for the follow-up investigation!

The "keep the first report" is definitely a bad policy. No good scientific or investigative study ends with just the initial information. I think there are likely at least two reasons for the policy. First, the CDC/FDA never wanted the VAERS system. Congress forced it on them. I suspect they despise it, especially because it's open -- anyone can submit reports and anyone can view reports. This also means that reporters can check whether their reports have been included and verify their accuracy (unlike almost any other human-reported scientific data set). The openness of the system allows an independent assessment of adverse effects that CDC/FDA can't control, and it allows skilled analysts like you to investigate matters they would like kept in the dark. The "keep the first report" policy allows VAERS to minimize the negative outcomes recorded in the public version of the database. Indeed, any reporter who makes more than one report is truly committed and likely not only believes the symptoms are genuine adverse effects but may also have good evidence to support their claims. A probable second reason for the policy is that it creates less work for the contractor that administers the VAERS (contracting the work out shows how little CDC/FDA care about VAERS). The contractor doesn't want to do anything extra, and CDC/FDA don't want to pay more for a feature that they don't want.

Expand full comment
5 more comments...

No posts